TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kintor Pharmaceutical Ltd ( (HK:9939) ) has provided an update.
Kintor Pharmaceutical Limited announced that all proposed resolutions at their Annual General Meeting (AGM) on June 10, 2025, were passed by shareholders via poll. The AGM saw the re-election of several directors and the re-appointment of PricewaterhouseCoopers as the company’s auditor. This successful AGM reflects the company’s stable governance and continued commitment to its strategic goals, positively impacting its stakeholders and reinforcing its position in the pharmaceutical industry.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on developing and commercializing innovative therapies for unmet medical needs, with a market focus on providing solutions in the healthcare sector.
Average Trading Volume: 3,614,295
Technical Sentiment Signal: Buy
Current Market Cap: HK$638.4M
Find detailed analytics on 9939 stock on TipRanks’ Stock Analysis page.